Literature DB >> 11000159

Percutaneous injection of thrombin for the treatment of pseudoaneurysms after catheterization: an alternative to sonographically guided compression.

J A Pezzullo1, D E Dupuy, J J Cronan.   

Abstract

OBJECTIVE: The purpose of our study was to determine the efficacy of percutaneous thrombin treatment for iatrogenic pseudoaneurysms of the femoral artery in comparison with sonographically guided compression repair. SUBJECTS AND METHODS: Twenty-three pseudoaneurysms occurring after catheterization were treated percutaneously with an initial injection of 1.0 mL of thrombin solution via a 22-gauge spinal needle under continuous sonographic guidance. Four patients required the additional injection of 1.0-4.0 mL of thrombin for complete thrombosis. Repeated sonography was performed 24 hr after injection. Additionally, we compared our results with those of a control group by reviewing the imaging findings and medical records of 16 patients who underwent sonographically guided compression of iatrogenic pseudoaneurysms between January 1998 and July 1998.
RESULTS: Twenty-two of 23 pseudoaneurysms occurring after catheterization were successfully treated with percutaneous thrombin injection. One recurrence was identified 24 hr after injection in a patient who experienced a significant complication. Procedure time was limited to 15 min with an overall success rate of 96%. Retrospectively, 18 iatrogenic pseudoaneurysms were identified in 16 patients. Six (60%) of 10 pseudoaneurysms were successfully compressed under sonographic guidance, with an average time to thrombosis of 32 min. Compression was unsuccessful for four pseudoaneurysms with an average compression time of 45 min. Compression could not be performed in seven patients (39%). The overall success rate of sonographically guided repair was 60%.
CONCLUSION: Preliminary evidence suggests that sonographically guided percutaneous thrombin injection is a safe and effective method of treatment for iatrogenic pseudoaneurysms and offers significant advantages over conventional sonographically guided compression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11000159     DOI: 10.2214/ajr.175.4.1751035

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

1.  A traumatic false aneurysm of the ankle: an unusual bump on the forefoot.

Authors:  Hugo T C Veger; Willem-Maarten Bosman; Maartje A van den Broek; Ewan D Ritchie; Paul Ph Hedeman Joosten
Journal:  BMJ Case Rep       Date:  2014-10-03

2.  Transplant renal artery false aneurysm: case report and literature review.

Authors:  Khalifa N Al-Wahaibi; Shahid Aquil; Rashid Al-Sukaiti; Dawood Al-Riyami; Qassim Al-Busaidi
Journal:  Oman Med J       Date:  2010-10

3.  Combined percutaneous thrombin injection and endovascular treatment of gastroduodenal artery pseudoaneurysm (PAGD): case report.

Authors:  Gianpaolo Carrafiello; Domenico Laganà; Chiara Recaldini; Monica Mangini; Domenico Lumia; Andrea Giorgianni; Anna Leonardi; Carlo Fugazzola
Journal:  Emerg Radiol       Date:  2007-01-31

4.  Percutaneous thrombin injection for the treatment of a post-pancreatitis pseudoaneurysm.

Authors:  S Puri; A A Nicholson; D J Breen
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

5.  Pseudoaneurysm as a complication of ankle arthroscopy.

Authors:  Olubusola A Brimmo; Selene G Parekh
Journal:  Indian J Orthop       Date:  2010-01       Impact factor: 1.251

6.  Iatrogenic Femoral Artery Pseudoaneurysm (REVIEW OF TREATMENT OPTIONS).

Authors:  Omid Hashemi Fard
Journal:  ARYA Atheroscler       Date:  2010

7.  Percutaneous Thrombin Injection for Treatment of a Splenic Artery Aneurysm.

Authors:  Frederick Chen; J Scott Kriegshauser; Eric A Huettl; Catherine C Roberts
Journal:  Radiol Case Rep       Date:  2015-11-06

Review 8.  Risks and complications of coronary angiography: a comprehensive review.

Authors:  Morteza Tavakol; Salman Ashraf; Sorin J Brener
Journal:  Glob J Health Sci       Date:  2012-01-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.